Pemigatinib is made to hit cholangiocarcinomas that have FGFR2 fusions. It’s an FGFR1-4 inhibitor, so it stops those fibroblast growth factor receptors from getting active, which are big players in tumor growth and spreading. You’ve got choices with the strength, like 4.5 mg, 9 mg, and the 13.5 mg.
But the go-to is that 13.5 mg pill, and you take it everyday for 14 days in every 21-day cycle. So, this schedule aims to hit the exact time when the tumor cells are most vulnerable, making it a better treatment plan. Each bottle is packed with 14 tabs to make sure you’ve got enough for a whole cycle.
